These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28366905)

  • 41. Healthcare priority setting in Kenya: a gap analysis applying the accountability for reasonableness framework.
    Bukachi SA; Onyango-Ouma W; Siso JM; Nyamongo IK; Mutai JK; Hurtig AK; Olsen OE; Byskov J
    Int J Health Plann Manage; 2014; 29(4):342-61. PubMed ID: 23775594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Priority setting in surgery: improve the process and share the learning.
    Martin DK; Walton N; Singer PA
    World J Surg; 2003 Aug; 27(8):962-6. PubMed ID: 12784149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rationing cancer treatment: a qualitative study of perceptions of legitimate limit-setting.
    Feiring E; Wang H
    BMC Health Serv Res; 2018 May; 18(1):342. PubMed ID: 29743065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The accountability problem of the National Institute for Health and Clinical Excellence.
    Hasman A
    Med Law; 2008 Mar; 27(1):83-93. PubMed ID: 18592883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The National Institute for Health and Clinical Excellence (NICE) and drug treatment for Alzheimer's disease.
    Iliffe S
    CNS Drugs; 2007; 21(3):177-84. PubMed ID: 17338591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Priority setting up close.
    Russell B; deVlaming D
    J Clin Ethics; 2011; 22(1):61-70. PubMed ID: 21595356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The (possible) impact of comparative effectiveness research on pharmaceutical industry decision making.
    Chalkidou K
    Clin Pharmacol Ther; 2010 Mar; 87(3):264-6. PubMed ID: 20160745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. At the center of health care policy making: the use of health technology assessment at NICE.
    Stevens AJ; Longson C
    Med Decis Making; 2013 Apr; 33(3):320-4. PubMed ID: 23519880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Influence of Cost-Effectiveness and Other Factors on Nice Decisions.
    Dakin H; Devlin N; Feng Y; Rice N; O'Neill P; Parkin D
    Health Econ; 2015 Oct; 24(10):1256-1271. PubMed ID: 25251336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Procedural justice and the individual participant in priority setting: Doctors' experiences.
    Gallagher S; Little M
    Soc Sci Med; 2019 May; 228():75-84. PubMed ID: 30889515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Public funding of new cancer drugs: Is NICE getting nastier?
    Mason AR; Drummond MF
    Eur J Cancer; 2009 May; 45(7):1188-1192. PubMed ID: 19138512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A technocratic fix to the "legitimacy problem"? The Blair government and health care rationing in the United Kingdom.
    Syrett K
    J Health Polit Policy Law; 2003 Aug; 28(4):715-46. PubMed ID: 12956521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advancing methods for health priority setting practice through the contribution of systems theory: Lessons from a case study in Ethiopia.
    Petricca K; Bekele A; Berta W; Gibson J; Pain C
    Soc Sci Med; 2018 Feb; 198():165-174. PubMed ID: 29367105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patients' views of explicit rationing: what are the implications for health service decision-making?
    Devlin N; Appleby J; Parkin D
    J Health Serv Res Policy; 2003 Jul; 8(3):183-6. PubMed ID: 12869346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ensuring relevance for Cochrane reviews: evaluating processes and methods for prioritizing topics for Cochrane reviews.
    Nasser M; Welch V; Tugwell P; Ueffing E; Doyle J; Waters E
    J Clin Epidemiol; 2013 May; 66(5):474-82. PubMed ID: 22521577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The ethics of grandfather clauses in healthcare resource allocation.
    Wester G; Gibson Rand LZ; Lu C; Sheehan M
    Bioethics; 2021 Feb; 35(2):151-160. PubMed ID: 33043477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Priority setting in HIV/AIDS control in West Java Indonesia: an evaluation based on the accountability for reasonableness framework.
    Tromp N; Prawiranegara R; Subhan Riparev H; Siregar A; Sunjaya D; Baltussen R
    Health Policy Plan; 2015 Apr; 30(3):345-55. PubMed ID: 24740708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Setting Healthcare Priorities at the Macro and Meso Levels: A Framework for Evaluation.
    Barasa EW; Molyneux S; English M; Cleary S
    Int J Health Policy Manag; 2015 Sep; 4(11):719-32. PubMed ID: 26673332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Piloting the development of a cost-effective evidence-informed clinical pathway: managing hypertension in Jordanian primary care.
    Chalkidou K; Lord J; Obeidat NA; Alabbadi IA; Stanley AG; Bader R; Momani A; O'Mahony RM; Qatami L; Cutler D
    Int J Technol Assess Health Care; 2011 Apr; 27(2):151-8. PubMed ID: 21473813
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.